The Food and Drug Administration Dec. 4 announced empty IV bags have been added to its Medical Device Shortages List, and ...
A history of lead in gasoline may be behind tens of millions of mental health conditions in the United States, according to ...
CMS has reached agreements with bluebird bio and Vertex Pharmaceuticals for their FDA-approved gene therapies for sickle cell disease — Casgevy and Lyfgenia, respectively.
The U.S. Food and Drug Administration has approved Merus NV's therapy that targets a particular gene, expanding treatment ...
A California farm expanded a recall of raw milk sold in stores and halted production after state health and agriculture ...
Novartis failed to persuade a U.S. appeals court on Wednesday to halt MSN Pharmaceuticals' proposed generic of Novartis' ...